ESG

An advocacy group challenges the University of Denver's animal-law program, demanding proof of impact and raising questions about donor funds.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

China's MOMOTOY brings its AI-powered, emotionally intelligent art toys to the U.S., aiming to redefine collectibles with personality and connection.

Hydro-Québec plans to double electricity rates for large data centers, a strategic move to manage soaring demand and revalue its clean energy resources.

An international team, backed by a $2M grant from a global consortium and Microsoft, will use AI to personalize care for a long-overlooked disease.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

AS Tallink Grupp's annual profit fell sharply in 2025, a result masked by a strong fourth-quarter rebound fueled by vessel sales and a key accounting change.

A landmark deal will deploy advanced Belgian particle accelerators across India, aiming to revolutionize cancer diagnostics and patient access in a booming market.

Despite a massive accounting-driven net loss, Renault Group's 2025 results reveal robust operational health, sales growth, and a successful EV push.

The European feed giant posts a record year, fueled by strategic acquisitions and market tailwinds, signaling an aggressive expansion across the continent.

A new 13 MW solar array at the Poland Spring plant provides clean power, cost certainty, and a major boost to Maine's ambitious renewable energy goals.

A five-month migration of 24,000 members highlights a major trend: Australia's super funds are betting on global tech giants for a digital future.

As Cherry Hill Mortgage preps its 2025 results, investors eye dividends and strategy amid high interest rates and a challenging housing market.

The insurtech firm posted massive revenue growth driven by its AI platform, but one-time IPO costs obscure the full strength of its 2025 performance.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

Wyndham Hotels & Resorts reports record development but takes a major Q4 loss from a franchisee's insolvency, yet signals confidence with a dividend hike.

Aurora executives face Wall Street at key March conferences to justify high cash burn with a clear path to commercializing their driverless truck tech.

Seer, Inc. heads to the TD Cowen conference, putting its innovative proteomics technology and market strategy under the investor microscope.